List of insiders holdings for Trillium Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Reynolds Thomas C Director | 2021-01-04 20:20:27 | 643,532 0 | 643,532 | Form 3 |
| KIRKMAN ROBERT L Director | 2021-01-04 20:13:39 | 519,290 0 | 519,290 | Form 3 |
| Skvarka Jan President and CEO | 2021-11-19 13:20:57 | 0 0 | 0 | Form 4 |
| TAYTON-MARTIN HELEN KATRINA Director | 2021-11-19 13:22:11 | 0 0 | 0 | Form 4 |
| Uger Robert Chief Scientific Officer | 2021-11-19 13:23:23 | 0 0 | 0 | Form 4 |
| Petrova Penka Chief Development Officer | 2021-11-19 13:24:24 | 0 0 | 0 | Form 4 |
| Bruns Ingmar Chief Medical Officer | 2021-11-19 13:25:14 | 0 0 | 0 | Form 4 |
| MACKEY CATHERINE J Director | 2021-11-19 13:26:15 | 0 0 | 0 | Form 4 |
| Looker Benjamin General Counsel | 2021-11-19 13:27:14 | 0 0 | 0 | Form 4 |
| Kamarck Michael E. Director | 2021-11-19 13:28:05 | 0 0 | 0 | Form 4 |
| Parsons James T. Chief Financial Officer | 2021-11-19 13:29:14 | 0 0 | 0 | Form 4 |
| BESHAR LUKE M Director | 2021-11-19 13:30:09 | 0 0 | 0 | Form 4 |
| Harrison Rosemary See Remarks | 2021-11-19 13:30:58 | 0 0 | 0 | Form 4 |
| Myers Scott Dunseth Director | 2021-11-19 13:33:02 | 0 0 | 0 | Form 4 |
| Pucci Paolo Director | 2021-11-19 13:33:49 | 0 0 | 0 | Form 4 |
| Walker Paul Edward Director | 2021-11-19 15:34:15 | 0 0 | 0 | Form 4 |